+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 21Years +
All Genders
ID07554352

Observational Study of RespirAI Home Monitoring Software for Early Detection of COPD Exacerbations in Adults

Led by RespirAI US Inc · Updated on 2026-08-10

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of a home-monitoring device called RespirAI in adults aged over 21 who have physician-diagnosed COPD and are at high risk for exacerbations. The study focuses on early detection of COPD exacerbations by analyzing data collected from the device using an AI-based algorithm. This research aims to compare the devices predictions with clinically documented exacerbations to assess how accurately the device detects these events. Participants will wear the RespirAI software-based monitoring device for a period of six months. During this time, the device will continuously collect data related to their COPD condition. The study does not involve any additional treatment but observes and records data to evaluate the devices performance in real-world settings. Throughout the six-month period, participants will be monitored for COPD exacerbations, and data from the device will be compared against clinical records of exacerbation events. Researchers will measure key outcomes such as the sensitivity of the device in detecting exacerbations and the rate of false alarms over this time. The study involves no interventions beyond wearing the device, and participants are observed to understand how well the device can support early COPD exacerbation detection.

CONDITIONS

Brief Title

Early Detection of COPD Exacerbations Using Home Monitoring Device

Research Team

T

Tamar Sobol

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here